Thomas J Bartow MD
Rheumatoid Arthritis & Related, Vasculitis
Rheumatology at Marshfield Clinic
Join to view full profile
1000 N Oak AveMarshfield, WI 54449
Phone+1 715-387-5511
Dr. Bartow is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Bartow is a rheumatologist based in Marshfield, WI, specializing in rheumatoid arthritis and vasculitis. He completed his residency in Internal Medicine at Rush University Medical Center and a fellowship in Rheumatology at Johns Hopkins University. His education began at Stony Brook University Health Sciences Center School of Medicine. Dr. Bartow has experience with temporomandibular and hip rheumatoid arthritis. He has been published multiple times, with his work being frequently cited, including notable research in complement inhibition and myocardial inflammation. He has been recognized as a fellow by the American College of Physicians and the American College of Rheumatology and received the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2012.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 1985 - 1990
Rush University Medical CenterResidency, Internal Medicine, 1980 - 1983
Stony Brook University Health Sciences Center School of MedicineClass of 1980
Certifications & Licensure
MI State Medical License 2023 - 2029
WI State Medical License 1990 - 2027
MD State Medical License 1985 - 1990
IL State Medical License 1981 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cattails Software Suite, Marshfield Clinic, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Cattails Software Suite with 3rd Party Reporting, Marshfield Clinic, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Cattails Software Suite with 3rd Party Reporting, Marshfield Clinic, 2012, 2014-2017
Publications & Presentations
PubMed
- 65 citationsMapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.Kimberly R. Kalli, Peihong Hsu, Thomas J. Bartow, Joseph M. Ahearn, Alan K. Matsumoto
The Journal of Experimental Medicine. 1991-12-01 - 785 citationsSoluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosisHarlan F. Weisman, Thomas J. Bartow, Michelle K. Leppo, Henry C. Marsh, Gerald R. Carson
Science. 1990-07-13 - 47 citationsRecombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium.Harlan F. Weisman, Bartow T, Michelle K. Leppo, Michael P. Boyle, Marsh Hc
Transactions of the Association of American Physicians. 1990-01-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: